Published January 20, 2012, 10:59 AM
MS drug from Novartis investigated after at least 11 deaths
The deaths raise concerns Gilenya could trigger heart problems after patients take their first dose, according to a statement issued Friday by the European Medicines Agency. The agency, which is now investigating the drug, said it isn't clear if it caused the deaths.By: Associated Press,
RSS Feeds